Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Sunesis Pharmaceuticals
Sunsen Pharmaceuticals is developing new oncology therapeutics for the treatment of solid and hematologic cancers.
Sector
Subsector
Keywords
Location
total rounds
total raised
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for cancer and other major diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Akeso Biopharma
Akeso Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and immunology.
Sector
Subsector
Location
total rounds
total raised
Antengene Corporation
Antengene is a global biopharmaceutical company focused on developing innovative oncology therapies.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 28.09.2010. Their latest investor NGN Capital. Their latest round Series C
NGN Capital
NGN Capital is a New York-based venture capital firm that specializes in healthcare investments in the US and Europe.
Sector
Subsector
Location
count Of Investments
count Of Exists
Wexford Capital
Wexford Capital manages hedge and private equity funds, boasting $6.5 billion of assets under management.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors4
Number of lead investors
Number of investors
NGN Capital
NGN Capital is a New York-based venture capital firm that specializes in healthcare investments in the US and Europe.
Sector
Subsector
Location
count Of Investments
count Of Exists
Wexford Capital
Wexford Capital manages hedge and private equity funds, boasting $6.5 billion of assets under management.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Sonostar Capital Partners
Sonostar Capital Partners, LLC pools investment capital to pursue entrepreneurial opportunities.
Sector
Subsector
Keywords
Location
count Of Investments
People
Founders1
Mark Pruzanski
Mark Pruzanski is the Chairman and Chief Executive Officer of Versanis Bio. He previously worked at National Geographic as an International Council of Advisors. Mark Pruzanski attended The Johns Hopkins University - Paul H. Nitze School of Advanced International Studies (SAIS).
current job
Mark Pruzanski